Andrographis: Respiratory Benefits, Evidence, Uses, and Safety

Andrographis (Andrographis paniculata) is a bitter medicinal herb used in several traditional systems for colds, fever, sore throat, and other respiratory complaints. Unlike many herbs promoted for “immune support,” andrographis has been studied in randomized trials for acute respiratory symptoms. That gives it a more substantial human evidence base than a purely laboratory claim—but the evidence still needs careful interpretation.

Andrographis at a Glance: What the Evidence Suggests

Some clinical trials and meta-analyses suggest that andrographis preparations may reduce cough, sore throat, overall symptom severity, or time to recovery in uncomplicated acute respiratory tract infections. A 2017 systematic review and meta-analysis included 33 randomized trials involving more than 7,000 participants and found signals of symptom improvement.

The important limitation is quality. The same review reported substantial heterogeneity, inconsistent reporting of product manufacturing and quality control, and generally poor methodological quality. NCCIH also treats the evidence cautiously and does not regard andrographis as established therapy for preventing or treating colds.

• Most plausible role: short-term symptom support in uncomplicated respiratory illness.
• What remains uncertain: the size and consistency of benefit across different products.
• What the evidence does not establish: that andrographis kills a respiratory pathogen in the body or replaces antibiotics for bacterial infection.

What Andrographis Is and Why Formulation Matters

Andrographis products are made from Andrographis paniculata, a herb whose major studied constituent is andrographolide. Commercial preparations vary widely. Some trials use standardized extracts, some use combinations with other herbs, and some do not report enough manufacturing detail to know how closely the tested product resembles a supplement on a store shelf.

This matters because evidence belongs first to the preparation that was actually studied. A positive trial of a standardized extract does not automatically prove that a tea, capsule, tincture, combination product, or differently concentrated extract will have the same effect.

Human Evidence for Colds and Acute Respiratory Symptoms

The human evidence is strongest for symptom outcomes rather than infection eradication. Trials have measured cough, sore throat, overall symptom scores, time away from work, and time to symptom resolution. In pooled analyses, andrographis sometimes performs better than placebo or usual care for these outcomes.

That is clinically interesting, but it should not be overstated. Respiratory tract infections are a broad category. Many are viral and self-limited; some are bacterial; some symptoms arise from inflammation or irritation rather than infection at all. A reduction in cough or sore-throat severity does not prove that a pathogen was eliminated, nor does it identify whether antibiotics were unnecessary in a particular patient.

The best summary is therefore possible symptomatic benefit with limited certainty. The evidence is promising enough to justify further research, but not strong enough to claim consistent effectiveness for every product or every respiratory infection.

What the Regulatory Evidence Context Tells Us

The European Medicines Agency completed an assessment of Andrographis paniculata leaf but did not adopt an EU herbal monograph. That outcome should be interpreted carefully. It does not prove that andrographis is ineffective, but it does mean the evidence did not result in a harmonized European monograph establishing a standard accepted medicinal use.

Regulatory context is useful because herbal medicines often vary in species, plant part, preparation, standardization, and dose. When these variables are not consistent across the evidence base, translating trial findings into a broad public recommendation becomes more difficult.

Antimicrobial Claims Versus Respiratory Symptom Evidence

Andrographis and andrographolide have been studied for antimicrobial, antiviral, anti-inflammatory, and immune-related mechanisms. Those findings can support biological plausibility, but they should not be merged with the human symptom data as though they prove the same thing.

There are several levels of evidence:

• Laboratory activity can show whether a compound affects a microorganism or cellular pathway under controlled conditions.
• Human symptom trials can show whether people report less cough, sore throat, or shorter illness.
• Clinical infection-treatment evidence would need to show that a defined preparation safely improves meaningful outcomes in people with a diagnosed infection.

Andrographis has human symptom evidence, but that does not make it a “natural antibiotic.” A person with bacterial pneumonia, a complicated sinus infection, or another serious bacterial illness should not substitute andrographis for indicated antimicrobial treatment.

Safety, Side Effects, Interactions, Pregnancy, and Children

Safety data from clinical studies suggest that oral andrographis preparations are often tolerated reasonably well, but adverse effects occur. A systematic review of safety data found that nonserious adverse events were not rare, with gastrointestinal and skin-related effects among the most commonly reported.

Formulation matters here too. Herbal oral preparations are different from concentrated injectable andrographolide derivatives, which have been associated with serious allergic reactions in some settings. Evidence from one route or formulation should not be applied casually to another.

• Pregnancy and breastfeeding: robust safety evidence is lacking, so concentrated medicinal use should be avoided unless a qualified clinician determines otherwise.
• Children: some studies have included children, but products and age-specific directions vary; pediatric use should be product-specific and professionally reviewed when uncertainty exists.
• Medication interactions: people taking prescription medicines or managing chronic illness should review andrographis with a pharmacist or clinician before use.
• Adverse reactions: stop use and seek appropriate advice for concerning rash, swelling, breathing symptoms, severe gastrointestinal effects, or other significant reactions.

When Respiratory Illness Needs Medical Assessment

Symptom support should never obscure the course of an illness. Seek prompt medical assessment for difficulty breathing, chest pain, confusion, severe dehydration, bluish lips or face, persistent or rapidly worsening fever, severe weakness, or a sudden deterioration after initial improvement.

Persistent symptoms also deserve attention when they do not follow an expected self-limited course. People who are pregnant, immunocompromised, very young, frail, or living with significant heart or lung disease may need earlier evaluation.

For bacterial infections that require antibiotics, timing matters. An herbal product should not be used to justify postponing indicated diagnosis or treatment.

How to Use the Evidence Responsibly

If someone chooses an andrographis product for short-term respiratory symptom support, the most useful questions are: What exact preparation is this? Is the product standardized? Does its label identify the extract or active constituents clearly? Does the evidence apply to this formulation? Is the person taking medicines or in a higher-risk group?

For broader context on how herbal symptom evidence differs from infection treatment, see Mayobook’s Herbal Antibiotics resource and the Herbal Medicine topic hub.

Bottom Line

Andrographis has more human respiratory research than many herbs promoted as antimicrobials, and some trials suggest that certain preparations may reduce the severity or duration of uncomplicated respiratory symptoms. The evidence is still limited by study quality, formulation differences, and heterogeneity. Its most defensible role is therefore symptom-focused and preparation-specific—not as a proven pathogen-clearing treatment or a substitute for antibiotics when bacterial infection requires them.